Trethera Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Trethera is a clinical-stage biotechnology company based in Sherman Oaks, California, focused on developing therapies for cancer and autoimmune diseases. Its strategy targets the salvage pathway, a metabolic process that supports diseased cell growth, with the aim of slowing disease progression and improving patient outcomes. The leadership team brings together experienced scientists, industry veterans, and biotech innovators guiding the company through early clinical development. The company is mid-sized, operating with a compact team. In April 2026, Trethera announced the appointment of M. Andrew Woodmansee to its Board of Directors.